false
Catalog
The 8-hour Buprenorphine Training - PART 1 - 2/11/ ...
The Half and Half Course Agenda
The Half and Half Course Agenda
Back to course
Pdf Summary
This document provides an overview of the PCSS Half and Half course, which focuses on office-based treatment for opioid use disorders. The course is divided into two parts, with Part 1 lasting 4.25 hours. The document emphasizes that the funding for this initiative is partially supported by grant no. 1H79TI081968 from SAMHSA. The views expressed in the materials, as well as by speakers and moderators, do not necessarily reflect the official policies of the Department of Health and Human Services. Additionally, the mention of trade names, commercial practices, and organizations does not imply endorsement by the U.S. Government.<br /><br />Part 1 of the course covers different aspects of opioid use disorder treatment with buprenorphine/naloxone. It begins with a brief overview lasting 0.5 hours, followed by a section on patient evaluation lasting 0.75 hours. Specialty topics are then discussed for 0.75 hours, followed by a case study section lasting 0.25 hours. The clinical uses of buprenorphine are covered in a 0.5-hour session, followed by another case study section lasting 0.25 hours. Urine drug testing is discussed for 0.5 hours, followed by another case study section lasting 0.25 hours. The course then concludes with an overview of clinical tools in a 0.25-hour session, followed by a Q&A session lasting 0.25 hours.<br /><br />Throughout the course, there will be 10 interactive polling questions that randomly appear. While respondents will not be graded on these questions, they are required for participation credit. Answering these questions helps the organizers gauge the participants' understanding of the material and confirms their engagement with the presentation and case studies.
Keywords
PCSS Half and Half course
office-based treatment
opioid use disorders
Part 1
SAMHSA grant
buprenorphine/naloxone
patient evaluation
specialty topics
urine drug testing
clinical tools
×
Please select your language
1
English